Search Results - "Balesano, Amanda"
-
1
The Role of Alcohol Dehydrogenase in Drug Metabolism: Beyond Ethanol Oxidation
Published in The AAPS journal (07-01-2021)“…Alcohol dehydrogenases (ADHs) are most known for their roles in oxidation and elimination of ethanol. Although less known, ADHs also play a critical role in…”
Get full text
Journal Article -
2
The Metabolism and Disposition of Brepocitinib in Humans and Characterization of the Formation Mechanism of an Aminopyridine Metabolite
Published in Drug metabolism and disposition (17-06-2024)“…Brepocitinib is an oral once-daily Janus kinase 1 and Tyrosine kinase 2 selective inhibitor currently in development for the treatment of several autoimmune…”
Get full text
Journal Article -
3
Defining the Selectivity of Chemical Inhibitors Used for Cytochrome P450 Reaction Phenotyping: Overcoming Selectivity Limitations with a Six-Parameter Inhibition Curve-Fitting Approach
Published in Drug metabolism and disposition (01-09-2022)“…The utility of chemical inhibitors in cytochrome P450 (CYP) reaction phenotyping is highly dependent on their selectivity and potency for their target CYP…”
Get full text
Journal Article -
4
An improved method for cytochrome p450 reaction phenotyping using a sequential qualitative-then-quantitative approach
Published in Drug metabolism and disposition (01-09-2022)“…Cytochrome P450 reaction phenotyping to determine the fraction of metabolism values (f ) for individual enzymes is a standard study in the evaluation of a new…”
Get full text
Journal Article -
5
The Comparison of Machine Learning and Mechanistic In Vitro–In Vivo Extrapolation Models for the Prediction of Human Intrinsic Clearance
Published in Molecular pharmaceutics (06-11-2023)“…Accurate prediction of human pharmacokinetics (PK) remains one of the key objectives of drug metabolism and PK (DMPK) scientists in drug discovery projects…”
Get full text
Journal Article -
6
Discovery of First Branched-Chain Ketoacid Dehydrogenase Kinase (BDK) Inhibitor Clinical Candidate PF-07328948
Published in Journal of medicinal chemistry (19-11-2024)“…Inhibition of branched-chain ketoacid dehydrogenase kinase (BDK or BCKDK), a negative regulator of branched-chain amino acid (BCAA) metabolism, is hypothesized…”
Get full text
Journal Article -
7
Discovery of SARS-CoV-2 papain-like protease (PL pro ) inhibitors with efficacy in a murine infection model
Published in Science advances (30-08-2024)“…Vaccines and first-generation antiviral therapeutics have provided important protection against COVID-19 caused by severe acute respiratory syndrome…”
Get full text
Journal Article